Gimeracil is a pharmaceutical intermediate used in the manufacturing of combination cancer therapies. It is a chlorinated heterocyclic compound with a single aromatic ring and moderate lipophilicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 103766-25-2
Aprocitentan
pharmaceutical raw material
L-(+)-methylenetetrahydrofolic acid
pharmaceutical raw material
Desloratadine
pharmaceutical raw material
(1-methylpiperidin-4-yl)(1-phenethyl-1H-imidazol-2-yl)methanone
pharmaceutical raw material
Hydrocortisone EP Impurity I
pharmaceutical raw material
Bromotheophylline
pharmaceutical raw material
Lacidipine
pharmaceutical raw material
Niraparib
pharmaceutical raw material
5-chloro-4-hydroxy-1H-pyridin-2-one
ZPLQIPFOCGIIHV-UHFFFAOYSA-N
C1=C(C(=CNC1=O)Cl)O